[1] |
Turner CL, Emery H, Collins AL, et al. Detection of 53 FBN1 mutations (41 novel and 12 recurrent) and genotype-phenotype correlations in 113 unrelated probands referred with Marfan syndrome, or a related fibrillinopathy[J]. Am J Med Genet A,2009,149A(2):161-170.
|
[2] |
Schrijver I, Liu W, Brenn T, et al. Cysteine substitutions in epidermal growth factor—like domains of fibrillin-l: distinct effects on biochemical and clinical phenotypes[J]. Am J Hum Genet,1999,65(4):1007-1020.
|
[3] |
Attansaio M, Lapini I, Evangelisti L, et al. FBN1 mutation screening of patients with Marfan syndrome and related disorders: Detection of 46 novel FBN1 mutations[J]. Clin Genet,2008,74(1):39-46.
|
[4] |
Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies[J]. J Med Genet,2000, 37(1):9-25.
|
[5] |
Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome[J]. J Med Genet,2010,47(7):476-485.
|
[6] |
Zadeh N, Bernstein JA, Niemi AK, et al. Ectopia lentis as the presenting and primary feature in Marfan syndrome[J]. Am J Med Genet A,2011,155A(11):2661-2668.
|
[7] |
Adès LC, Holman KJ, Brett MS, et al. Ectopia lentis phenotypes and the FBN1 gene[J]. Am J Med Genet A,2004,126A(3):284-289.
|
[8] |
Détaint D, Faivre L, Collod-Beroud G, et al. Cardiovascular manifestations in men and women carrying a FBN1 mutation[J]. Eur Heart J,2010,31(18):2223-2229.
|
[9] |
Whiteman P, Handford PA. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders[J]. Hum Mol Genet,2003,12(7):727-737.
|
[10] |
Milewicz DM1, Urbán Z, Boyd C. Genetic disorders of the elastic fiber system[J]. Matrix Biol,2000,19(6):47l-480.
|
[11] |
Reinhardt DP, Ono RN, Notbohm H, et al. Mutation in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome[J]. J Biol Chem,2000,275(16):12339-12345.
|